SUN PHARMA ADVANCED RESEARCH COMPANY
Back to Balance Sheet
|
SUN PHARMA ADVANCED RESEARCH COMPANY Last 5 Year Long Term Provisions History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|
| Long Term Provisions | ₹7.68 Cr | ₹6.05 Cr | ₹8.14 Cr |
What is the latest Long Term Provisions ratio of SUN PHARMA ADVANCED RESEARCH COMPANY ?
| Year | Long Term Provisions |
|---|---|
| Mar2025 | ₹7.68 Cr |
| Mar2024 | ₹6.05 Cr |
| Mar2023 | ₹8.14 Cr |
How is Long Term Provisions of SUN PHARMA ADVANCED RESEARCH COMPANY Trending?
| Years | Long Term Provisions | % Change | |
|---|---|---|---|
| Mar2025 | ₹7.68 Cr | 26.92 | |
| Mar2024 | ₹6.05 Cr | -25.68 | |
| Mar2023 | ₹8.14 Cr | - | |
Compare Long Term Provisions of peers of SUN PHARMA ADVANCED RESEARCH COMPANY
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMA ADVANCED RESEARCH COMPANY | ₹8,146.6 Cr | -9.5% | 9.5% | 58.6% | Stock Analytics | |
| PRIME FOCUS | ₹20,526.5 Cr | 8.5% | 8.9% | 66% | Stock Analytics | |
| SAGILITY | ₹19,708.4 Cr | 3.3% | 5.2% | 0.7% | Stock Analytics | |
| SYNGENE INTERNATIONAL | ₹16,980.3 Cr | 1.2% | -7.1% | -33.7% | Stock Analytics | |
| INTERNATIONAL GEMOLOGICAL INSTITUTE | ₹15,266.0 Cr | 3.4% | -4.3% | -11.9% | Stock Analytics | |
| INDEGENE | ₹12,288.4 Cr | 2.8% | -0.7% | -9.8% | Stock Analytics | |
SUN PHARMA ADVANCED RESEARCH COMPANY Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMA ADVANCED RESEARCH COMPANY | -9.5% |
9.5% |
58.6% |
| SENSEX | 0.9% |
2.2% |
-7.5% |
You may also like the below Video Courses